vs
Side-by-side financial comparison of Tonix Pharmaceuticals Holding Corp. (TNXP) and Worksport Ltd (WKSP). Click either name above to swap in a different company.
Tonix Pharmaceuticals Holding Corp. is the larger business by last-quarter revenue ($5.4M vs $4.7M, roughly 1.1× Worksport Ltd). On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs 62.0%). Worksport Ltd produced more free cash flow last quarter ($-6.3M vs $-41.5M). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs 47.4%).
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Worksport LtdWKSPEarnings & Financial Report
Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.
TNXP vs WKSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $4.7M |
| Net Profit | $-46.9M | — |
| Gross Margin | 80.4% | 30.1% |
| Operating Margin | -895.8% | -129.6% |
| Net Margin | -870.3% | — |
| Revenue YoY | 108.8% | 62.0% |
| Net Profit YoY | -112.2% | — |
| EPS (diluted) | $-4.28 | $-0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4M | $4.7M | ||
| Q3 25 | $3.3M | $5.0M | ||
| Q2 25 | $2.0M | $4.1M | ||
| Q1 25 | $2.4M | $2.2M | ||
| Q4 24 | $2.6M | $2.9M | ||
| Q3 24 | $2.8M | $3.1M | ||
| Q2 24 | $2.2M | $1.9M | ||
| Q1 24 | $2.5M | $512.6K |
| Q4 25 | $-46.9M | — | ||
| Q3 25 | $-32.0M | $-4.9M | ||
| Q2 25 | $-28.3M | $-3.7M | ||
| Q1 25 | $-16.8M | $-4.5M | ||
| Q4 24 | $-22.1M | — | ||
| Q3 24 | $-14.2M | $-4.1M | ||
| Q2 24 | $-78.8M | $-4.0M | ||
| Q1 24 | $-14.9M | $-3.7M |
| Q4 25 | 80.4% | 30.1% | ||
| Q3 25 | 58.4% | 31.3% | ||
| Q2 25 | -63.8% | 26.4% | ||
| Q1 25 | 61.2% | 17.7% | ||
| Q4 24 | 54.2% | 11.1% | ||
| Q3 24 | 44.9% | 7.9% | ||
| Q2 24 | -52.5% | 15.4% | ||
| Q1 24 | 33.1% | 7.3% |
| Q4 25 | -895.8% | -129.6% | ||
| Q3 25 | -1005.1% | -95.6% | ||
| Q2 25 | -1416.2% | -88.1% | ||
| Q1 25 | -660.9% | -190.0% | ||
| Q4 24 | -870.6% | -137.0% | ||
| Q3 24 | -551.2% | -125.1% | ||
| Q2 24 | -3501.6% | -203.5% | ||
| Q1 24 | -860.2% | -709.9% |
| Q4 25 | -870.3% | — | ||
| Q3 25 | -972.9% | -98.3% | ||
| Q2 25 | -1415.0% | -91.0% | ||
| Q1 25 | -692.8% | -199.1% | ||
| Q4 24 | -856.2% | — | ||
| Q3 24 | -503.6% | -132.4% | ||
| Q2 24 | -3567.8% | -208.9% | ||
| Q1 24 | -601.9% | -724.6% |
| Q4 25 | $-4.28 | $-0.65 | ||
| Q3 25 | $-3.59 | $-0.75 | ||
| Q2 25 | $-3.86 | $-0.71 | ||
| Q1 25 | $-2.84 | $-1.05 | ||
| Q4 24 | $2302.65 | $-1.14 | ||
| Q3 24 | $-22.68 | $-1.40 | ||
| Q2 24 | $-1920.85 | $-1.55 | ||
| Q1 24 | $-535.72 | $-1.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $207.6M | $5.9M |
| Total DebtLower is stronger | — | $2.7M |
| Stockholders' EquityBook value | $245.2M | $22.9M |
| Total Assets | $277.2M | $30.7M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $207.6M | $5.9M | ||
| Q3 25 | $190.1M | $3.8M | ||
| Q2 25 | $125.3M | $1.4M | ||
| Q1 25 | $131.7M | $5.1M | ||
| Q4 24 | $98.8M | $4.9M | ||
| Q3 24 | $28.2M | $1.9M | ||
| Q2 24 | $4.2M | $3.4M | ||
| Q1 24 | $7.0M | $3.5M |
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.9M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | $8.7M | $5.3M | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $10.8M | — |
| Q4 25 | $245.2M | $22.9M | ||
| Q3 25 | $231.1M | $19.8M | ||
| Q2 25 | $168.0M | $17.3M | ||
| Q1 25 | $180.4M | $20.1M | ||
| Q4 24 | $139.6M | $17.4M | ||
| Q3 24 | $74.2M | $16.4M | ||
| Q2 24 | $42.1M | $19.1M | ||
| Q1 24 | $108.1M | $18.9M |
| Q4 25 | $277.2M | $30.7M | ||
| Q3 25 | $252.4M | $27.0M | ||
| Q2 25 | $187.4M | $23.6M | ||
| Q1 25 | $192.9M | $26.7M | ||
| Q4 24 | $162.9M | $25.7M | ||
| Q3 24 | $95.0M | $24.9M | ||
| Q2 24 | $70.3M | $27.2M | ||
| Q1 24 | $135.3M | $27.3M |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.06× | 0.30× | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.6M | $-6.1M |
| Free Cash FlowOCF − Capex | $-41.5M | $-6.3M |
| FCF MarginFCF / Revenue | -770.4% | -132.4% |
| Capex IntensityCapex / Revenue | 34.8% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.2M | $-18.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.6M | $-6.1M | ||
| Q3 25 | $-28.8M | $-4.3M | ||
| Q2 25 | $-14.8M | $-3.1M | ||
| Q1 25 | $-16.6M | $-3.8M | ||
| Q4 24 | $-14.6M | $-2.2M | ||
| Q3 24 | $-18.8M | $-1.5M | ||
| Q2 24 | $-9.9M | $-3.6M | ||
| Q1 24 | $-17.6M | $-2.8M |
| Q4 25 | $-41.5M | $-6.3M | ||
| Q3 25 | $-29.7M | $-4.6M | ||
| Q2 25 | $-15.4M | $-3.2M | ||
| Q1 25 | $-16.6M | $-4.0M | ||
| Q4 24 | $-14.6M | $-2.2M | ||
| Q3 24 | $-18.8M | $-1.7M | ||
| Q2 24 | — | $-3.7M | ||
| Q1 24 | $-17.7M | $-3.0M |
| Q4 25 | -770.4% | -132.4% | ||
| Q3 25 | -904.1% | -92.1% | ||
| Q2 25 | -768.8% | -77.1% | ||
| Q1 25 | -682.8% | -180.4% | ||
| Q4 24 | -566.7% | -75.4% | ||
| Q3 24 | -666.5% | -54.5% | ||
| Q2 24 | — | -195.1% | ||
| Q1 24 | -712.4% | -586.7% |
| Q4 25 | 34.8% | 3.3% | ||
| Q3 25 | 29.2% | 7.3% | ||
| Q2 25 | 26.4% | 1.7% | ||
| Q1 25 | 0.2% | 9.0% | ||
| Q4 24 | 0.1% | 0.9% | ||
| Q3 24 | 0.3% | 5.3% | ||
| Q2 24 | 0.0% | 6.4% | ||
| Q1 24 | 4.4% | 41.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
WKSP
Segment breakdown not available.
